Product Code: GVR-3-68038-910-4
Positive Airway Pressure Devices Growth & Trends:
The global positive airway pressure devices market size is expected to reach USD 3.6 billion by 2030, registering a CAGR of 5.6% during the forecast period, according to a new report by Grand View Research, Inc. The healthcare industry is facing challenges owing to the rapidly growing prevalence of obstructive sleep apnea and sleep apnea-associated chronic comorbidities. Obstructive sleep apnea is a sleeping disorder, characterized by irregular breathing, thus providing insufficient oxygen to the brain. As per the global prevalence of obstructive sleep apnea estimates published in June 2022 by UpToDate, over 936 million individuals across the globe suffer from mild to severe sleep apnea.
Changing lifestyles owing to globalization and the adoption of unhealthy dietary habits are making individuals prone to obesity, Cardiovascular Diseases (CVDs), diabetes, and hypertension, which are forerunners of obstructive sleep apnea. As per the estimates published by the World Population Review, 36.2% of the U.S. population is diagnosed as obese. In addition, the rapidly increasing geriatric population coupled with increasing life expectancy is anticipated to contribute to the incidence rate of obstructive sleep apnea and directly drive the demand for positive airway pressure devices (PAP) devices. The COVID-19 pandemic restrained the growth of the market owing to multiple lockdowns and travel restrictions imposed by governments across the globe to curb the transmission rate.
In addition, the postponement of elective procedures and infrastructural changes in healthcare facilities to accommodate COVID-19 care facilities negatively impacted the procedural volume, which hindered market growth. Healthcare facilities and sleep centers recorded a declining trend in diagnostic and therapeutic procedural volume, restricting the growth of PAP devices. The American Academy of Sleep Medicine (AASM) introduced protocols to adopt virtual consultations to address the declining sleep studies volume. However, during the initial months of the pandemic, PAP machines were being used as the first line of treatment and as an alternative to ventilators in mechanical ventilation. Global government bodies are devising strategies to promote awareness levels among the population and promote the adoption of PAP machines. The availability of favorable reimbursement policies is further boosting product adoption.
Positive Airway Pressure Devices Market Report Highlights:
- The CPAP devices segment dominated the market in 2021 owing to the growing incidence of obstructive sleep apnea and CPAP is the first line of treatment as it is more economical than other PAP devices
- North America dominated the market in 2021 owing to the large patient pool, increasing disposable income levels, and presence of favorable insurance coverages
- The prevalence of obstructive sleep apnea in the male population of North America is recorded to be 15-30% and in females, it is 10-15%
- Key participants in the market are focusing on innovative product development strategies to expand their product portfolio and address the growing demand
- Some of the latest features being incorporated in PAP machines are noise reduction and softer material to enhance patient comfort and compliance
Table of Contents
Chapter 1. Methodology And Scope
- 1.1 Market Segmentation And Scope
- 1.2 Market Definition
- 1.3 Research Methodology
- 1.3.1 Information Procurement
- 1.3.1.1 Purchased Database:
- 1.3.1.2 Gvr's Internal Database
- 1.3.2 Primary Research:
- 1.4 Research Scope And Assumptions
- 1.5 List To Data Sources
Chapter 2. Executive Summary
- 2.1 Global Positive Airway Pressure Devices Market Outlook
- 2.2 Global Positive Airway Pressure Devices Market Segment Outlook
- 2.3 Global Positive Airway Pressure Devices Market Competitive Insight
- 2.4 Global Positive Airway Pressure Devices Snapshot
Chapter 3. Global Positive Airway Pressure Devices Market Variables, Trends, & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.1.2 Related/Ancillary Market Outlook
- 3.2 Penetration And Growth Prospect Mapping
- 3.3 Market Dynamics
- 3.3.1 Market Driver Analysis
- 3.3.2 Market Restraint Analysis
- 3.3.3 Industry Challenges
- 3.4 Global Positive Airway Pressure Devices Market Analysis Tools
- 3.4.1 Industry Analysis - Porter's
- 3.4.1.1 Bargaining Power Of The Suppliers
- 3.4.1.2 Bargaining Power Of The Buyers
- 3.4.1.3 Threats Of Substitution
- 3.4.1.4 Threats From New Entrants
- 3.4.1.5 Competitive Rivalry
- 3.4.2 Pestel Analysis
- 3.4.2.1 Political Landscape
- 3.4.2.2 Economic And Social Landscape
- 3.4.2.3 Technology Landscape
- 3.4.2.4 Legal Landscape
- 3.4.2.5 Technology Landscape
- 3.4.3 Regulatory Framework
- 3.4.3.1 Compliance Standards
- 3.4.4 Impact Of Covid-19 On Positive Airway Pressure Market
Chapter 4. Global Positive Airway Pressure Devices Market: Competitive Analysis
- 4.1 Recent Developments & Impact Analysis, By Key Market Participants
- 4.2 Company Market Share Analysis
- 4.3 Company Market Position Analysis
Chapter 5. Global Positive Airway Pressure Devices Market: Product Type Estimates & Trend Analysis
- 5.1 Definitions & Scope
- 5.2 Global Positive Airway Pressure Devices Market: Product Type Market Share Analysis, 2021 And 2030
- 5.3 Continuous Positive Airway Pressure (CPAP)
- 5.4 Automatic Positive Airway Pressure (APAP)
- 5.5 Bi-Level Positive Airway Pressure (BIPAP)
Chapter 6. Global Positive Airway Pressure Devices Market: Regional Estimates & Trend Analysis, By Product Type
- 6.1 Global Positive Airway Pressure Devices Market: Regional Movement Analysis
- 6.2 North America
- 6.2.1 North America Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.2.2 U.S.
- 6.2.2.1 U.S. Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.2.3 Canada
- 6.2.3.1 Canada Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.3 Europe
- 6.3.1 Europe Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.3.2 U.K.
- 6.3.2.1 U.K. Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.3.3 Germany
- 6.3.3.1 Germany Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.3.4 France
- 6.3.4.1 France Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.3.5 Italy
- 6.3.5.1 Italy Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.3.6 Spain
- 6.3.6.1 Spain Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.3.7 Russia
- 6.3.7.1 Russia Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.3.8 Portugal
- 6.3.8.1 Portugal Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.4 Asia Pacific
- 6.4.1 Asia Pacific Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.4.2 Japan
- 6.4.2.1 Japan Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.4.3 China
- 6.4.3.1 China Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.4.4 India
- 6.4.4.1 India Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.4.5 Australia
- 6.4.5.1 Australia Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.4.6 South Korea
- 6.4.6.1 South Korea Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.4.7 Singapore
- 6.4.7.1 Singapore Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.5 Latin America
- 6.5.1 Latin America Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.5.2 Brazil
- 6.5.2.1 Brazil Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.5.3 Mexico
- 6.5.3.1 Mexico Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.5.4 Argentina
- 6.5.4.1 Argentina Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.6 MEA
- 6.6.1 MEA Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.6.2 South Africa
- 6.6.2.1 South Africa Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.6.3 Saudi Arabia
- 6.6.3.1 Saudi Arabia Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
- 6.6.4 UAE
- 6.6.4.1 UAE Positive Airway Pressure Market Estimates And Forecasts, By Product Type, 2016-2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1 BMC MEDICAL CO. LTD.
- 7.1.1 Company Overview
- 7.1.2 Financial Performance
- 7.1.3 Product Benchmarking
- 7.1.4 Strategic Initiatives
- 7.2 DRIVE DEVILBLISS HEALTHCARE, INC
- 7.2.1 Company Overview
- 7.2.2 Financial Performance
- 7.2.3 Product Benchmarking
- 7.2.4 Strategic Initiatives
- 7.3 3B MEDICAL INC
- 7.3.1 Company Overview
- 7.3.2 Financial Performance
- 7.3.3 Product Benchmarking
- 7.3.4 Strategic Initiatives
- 7.4 KONINKLIJKE PHILIPS N.V. (PHILIPS RESPIRONICS)
- 7.4.1 Company Overview
- 7.4.2 Financial Performance
- 7.4.3 Product Benchmarking
- 7.4.4 Strategic Initiatives
- 7.5 RESMED
- 7.5.1 Company Overview
- 7.5.2 Financial Performance
- 7.5.3 Product Benchmarking
- 7.5.4 Strategic Initiatives
- 7.6 COMPUMEDICS LIMITED
- 7.6.1 Company Overview
- 7.6.2 Financial Performance
- 7.6.4 Product Benchmarking
- 7.6.4 Strategic Initiatives
- 7.7 CURATIVE MEDICAL
- 7.7.1 Company Overview
- 7.7.2 Financial Performance
- 7.7.3 Product Benchmarking
- 7.7.4 Strategic Initiatives
- 7.8 FISHER & PAYKEL HEALTHCARE LIMITED
- 7.8.1 Company Overview
- 7.8.2 Financial Performance
- 7.8.3 Product Benchmarking
- 7.8.4 Strategic Initiatives
- 7.9 APEX MEDICAL
- 7.9.1 Company Overview
- 7.9.2 Financial Performance
- 7.9.3 Product Benchmarking
- 7.9.4 Strategic Initiatives
- 7.10 INVACARE CORPORATION
- 7.10.1 Company Overview
- 7.10.2 Financial Performance
- 7.10.3 Product Benchmarking
- 7.10.4 Strategic Initiatives
- 7.11 SOMNETICS INTERNATIONAL, INC
- 7.11.1 Company Overview
- 7.11.2 Financial Performance
- 7.11.4 Product Benchmarking
- 7.11.4 Strategic Initiatives